Overview

The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy

Status:
RECRUITING
Trial end date:
2024-11-15
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of GM-CSF to preventing oral mucositis for patients with nasopharyngeal carcinoma receiving radiotherapy.
Phase:
PHASE2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Granulocyte-Macrophage Colony-Stimulating Factor